金所舌戰群儒

金所舌戰群儒
來源：清談天地 www.talkskyland.com

針對美國食品與藥物管理局(FDA)的官員們指責在中國常州製藥廠生產的肝素鈉（HEPARIN）藥品毒副作用明顯，導致全球11個國家的103個人死亡這一不良中毒國際事件，最近，中國藥品生物製品研究所的研究員金少鴻副所長在華盛頓新聞發布會上義憤填膺，據理力爭。

BaxterInternational Inc. recalled batches of heparin after 19 people hadfatal allergic reactions. Since then the FDA has been investigating theplant in China where heparin is manufactured from pig intestines.



金少鴻在美國FDA舉辦的“肝素鈉國際研討會”上作報告

金局長說，根據中國科學家的研究，中國生產的肝素藥品，沒有任何毒副作用。(He said Chinese scientists had foundno OSCS in batches of heparin associated with adverse reactions).

 

  

Jin Shaohong -- the deputy Director-General National
Institute for the Control of Pharmaceutical and Biological Products
(NICPBP) -- answers questions during a briefing on Heparin at the
Chinese Embassy in Washington. The New York Times has said that a
contaminated blood thinner from China linked to 81 deaths in the United States is present in drug supplies in 11 countries.

由於金所報告的結論與美國FDA的觀點不同，因此報告完畢後引起了與會專家們的極大關注和興趣，會後根據SFDA代表團和中國駐美大使館的安排，金少鴻在中國駐美使館舉行的記者招待會上接受中外記者提問。

LeRoy Hubley, whose wife and son died from an allergic reaction tocontaminated heparin, wipes his eyes while testifying at a House Oversight and Investigations subcommittee hearing on April 29, 2008.

Johanna Marie Staples weeps as she testifies to Congress about her husband's death following a reaction to heparin.

(Win McNamee/getty images)

對此，美國FDA藥物研究與評價中心的女主任WOODCOCK不得不說，藥物的反應有生物差異性，即便是在美國，也不是所有的人對肝素藥物都有毒副反應。言外之意，中國人的抗藥性比美國人強。

Janet Woodcock, director of FDA's Center for Drug Evaluation & Research. She also noted that reactions to the contaminated drug appear to depend onthe dose a person received and how quickly it was administered, and shesaid treatment standards can vary among countries. "Even in the U.S.,the adverse events did not occur in every individual who was exposed tocontaminated heparin, so there's some biologic variation," she added.

無獨有偶，曾經和中科院一個名老院士談話，院士也認為，由於長期的接觸有毒物品和食物，我們中國人的抗藥基因型，在全人類範圍內都堪稱出類拔萃，無與倫比的。

我們中國人從以前的缺醫少藥，一窮二白，到目前的全民對藥物產生抗性，再到生產的藥品滿天下，不能不說是曆史的進步和時代的盛舉！